<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02845154</url>
  </required_header>
  <id_info>
    <org_study_id>LDLDPURGE</org_study_id>
    <nct_id>NCT02845154</nct_id>
  </id_info>
  <brief_title>Intermittent Portal and Graft Purge in Living Donor Liver Transplantation</brief_title>
  <acronym>IPLDLT</acronym>
  <official_title>Intermittent Anti-grade Portal and Graft Purge Ameliorates Post-reperfusion Syndrome in Living Donor Liver Transplantation Recipients. A Prospective, Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-reperfusion syndrome and ischemia-reperfusion insult are a common well-known
      complication in liver transplantation. Several trials investigated variables that my
      contribute to the generation of these two complications for reducing their incidence and
      magnitude. The investigators will investigate the effect of acute conditioning of the
      recipients circulation to the vasoactive mediators in the graft as well as the congested
      intestine through intermittent purging of graft contents into the patient's systemic
      circulation in living donor liver transplantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are subjected to living donor liver transplantation. In this type of grafts, cold
      ischemia time is minimal and the graft contents of preservative solution are less than
      cadaveric grafts. The investigators in the current research use HTC as a preservative
      solution. These factors justified the possibility of purging the graft and portal blood
      contents into the patient systemic circulation. The exposure to these fluids in this trial
      will be in an intermittent manner: the portal vein will be declamped for 5 seconds followed
      by 30 seconds of portal clamping. This will be repeated twice. The primary outcome objective
      in this trial will be the incidence of post-reperfusion syndrome. Secondary objectives
      include the severity of PRS, the incidence and severity of ischemia-reperfusion injury, graft
      and patient's survival.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-reperfusion syndrome</measure>
    <time_frame>5 minutes after portal declamping</time_frame>
    <description>Reduced Mean arterial blood pressure to the predefined value</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Graft ischemia reperfusion injury</measure>
    <time_frame>one week post-operative</time_frame>
    <description>Pathological assessment of IR injury based on Suzuli score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of post-reperfusion syndrome</measure>
    <time_frame>5 minutes after portal declamping</time_frame>
    <description>% decrease in Mean arterial blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>One month patient mortality</measure>
    <time_frame>one month post-operative</time_frame>
    <description>Mortality within one post-operative month</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hypotension</condition>
  <condition>Ischemia Reperfusion Injury</condition>
  <arm_group>
    <arm_group_label>Control (bolus purge)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The portal vein clamp will be totally released after end of portal vein anastomosis and all graft and portal blood contents are allowed free and complete access to the systemic circulation via the inferior vena cave</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intermittent Purge</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The portal clamp will be released in situ for 5 seconds to allow purge of the graft and portal contents into the systemic circulation, followed by 30 seconds of portal clamping again. This will be followed by another two cycles of 5 seconds declamping and 30 seconds clamping , then, the portal clamp will be completely released.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>bolus purge</intervention_name>
    <description>complete and uninterrupted purge</description>
    <arm_group_label>Control (bolus purge)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intermittent purge</intervention_name>
    <description>intermittent portal purge</description>
    <arm_group_label>Intermittent Purge</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  living donor liver transplantation recipients

        Exclusion Criteria:

          -  Non
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr M Yassen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura Faculty of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amr M Yassen, MD</last_name>
    <phone>+201001497044</phone>
    <email>amryassen@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adel A Hassan, MD</last_name>
    <phone>+201007921234</phone>
    <email>apoadel2004@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Liver transplantation program - Gastroenterology surgical center</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amr M Yassen, MD</last_name>
      <phone>+201001497044</phone>
      <email>amryassen@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Waleed R alsarraf, MD</last_name>
      <phone>+201222322727</phone>
      <email>welsarraf@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Amr M Yassen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liver transplantation project - Gastroenterology surgical center - Mansoura university</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amr M Yassen, MD</last_name>
      <phone>+201001497044</phone>
      <email>amryassen@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Waleed R Elsarraf, MD</last_name>
      <phone>+201222322727</phone>
      <email>welsarraf@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Amr M Yassen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohamed Elmorshidy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elrefaiee Kandil, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Usama Elsaied, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Waleed R Elsarraf, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adel Hassan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastroenterology surgical center - Mansoura university</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amr M Yassen, MD</last_name>
      <phone>+201001497044</phone>
      <email>amryassen@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2015</study_first_submitted>
  <study_first_submitted_qc>July 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <last_update_submitted>March 24, 2017</last_update_submitted>
  <last_update_submitted_qc>March 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Amr Mohamed Yassen</investigator_full_name>
    <investigator_title>Professor of Anesthesia and Intensive Care</investigator_title>
  </responsible_party>
  <keyword>Ischemia reperfusion</keyword>
  <keyword>post-reperfusion syndrome</keyword>
  <keyword>living donor liver transplantation</keyword>
  <keyword>patient outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hypotension</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

